The Clinical neuropsychologist · 2025
Evaluating evidence for a neuropsychological toolkit to predict cognitive decline in PD: A systematic review.
Систематический обзорСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pourzinal Dana, King James, Sivakumaran Kumareshan, Yang Jihyun, McCann Emily, Mitchell Leander K, Brooks Deborah, Lehn Alexander, Liddle Jacki, Pachana Nancy A, Tinson Helen, Shrubsole Kirstine, Bailey Daniel X, Dissanayaka Nadeeka N
Аннотация
Objectives: Neuropsychological measures used to assess cognition in Parkinson's disease (PD) vary greatly across clinical and research settings. We conducted a systematic review to evaluate the literature pertaining to neuropsychological tools predictive of cognitive decline in PD, with a view to developing an evidence-based harmonized toolkit. Method: Following PRISMA guidelines, systematic literature searches for neuropsychological predictors of longitudinal cognitive decline in PD were performed for articles published up to August 2024 in PubMed, SCOPUS, Medline, PyscINFO and CINAHL databases. Quality was assessed using the Newcastle-Ottawa scale for individual studies and the GRADE system for each cognitive outcome. Results: Thirty-one relevant articles met inclusion criteria, with low to moderate risk of bias. Category fluency, Symbol Digit Modalities Test, Trail-making Test part A, Stroop word or color, immediate verbal memory, and Montreal Cognitive Assessment produced the highest grade of evidence (moderate), strongly supporting their predictive utility in PD. Stroop word-color, Letter Number Sequencing, pentagon copying, Trail-making Test part B, and delayed verbal and visual memory produced low quality evidence supporting their predictive utility in PD. Digit span forward and backward measures produced very low quality evidence, with consistent evidence against their predictive utility. Twelve additional measures produced very low quality of evidence due to insufficient studies or mixed results. Conclusions: The evidence base for key neuropsychological measures sensitive to cognitive decline in PD was evaluated in this systematic review. The findings will inform evidence-based tool selection for cognitive evaluations in PD and a PD-specific harmonized cognitive toolkit.